February 6, 2026

Aclarion secures $10.4M for back-pain diagnostic technology

Aclarion CEO Brent Ness presented at LSI Europe, an annual medtech/healthtech summit sponsored by Life Science Intelligence, in 2025. Photo courtesy Aclarion.
By

Aclarion Inc. (Nasdaq: ACON) recently raised $10.4 million through a stock sale, funding that extends the Broomfield-based health-care technology company’s operating runway into 2028, as it works to expand insurance coverage for its advanced imaging decision support tool for chronic back pain.

Lori DeBoer
Lori DeBoer covers startups for BizWest. She is a former editor for Boulder Magazine and a former contributing editor for America West Airlines Magazine, and her work has appeared in The New York Times, The Des Moines Register, Arizona Highways, Black Enterprise, Arizona Business Magazine and Working Woman. She has taught journalism at Arizona State University and CU Denver and works as a developmental editor and writing coach. She also paints horse and pet portraits.
Categories: Broomfield Life Sciences Today's News Aclarion Inc. Brent Ness

Related Posts

Sign up for BizWest Daily Alerts
Closing in 8 seconds...